Live Chat ×
Skip to main content

Aggressive B Cell Lymphomas


Evaluated by: 
David B. Kaminsky, M.D., FIAC, April 11, 2018
Original release date: May 23, 2018
Access to this course expires on:  April 11, 2021
CME/SAMs 2.5

Faculty: Megan S. Lim, M.D., Ph.D.

Learning Objectives:
  • Classify DLBCLs using currently available ancillary lab tests
  • Use immunohistochemical studies to identify clinically relevant subtypes of DLBCLs
  • Distinguish DLBCLs from other aggressive B-cell lymphomas using contemporary laboratory tests
  • Recognize the clinical management decisions and therapeutic implications associated with patients with aggressive B-cell lymphoma
  • Classify DLBCLs using currently available tools
  • Use immunohistochemical and molecular studies to identify clinically relevant subtypes of DLBCLs
  • Use immunohistochemical studies to identify therapeutic targets
  • Distinguish between subtypes of high grade B-cell lymphomas
  • Describe genetic alterations that are present in distinct subtypes of DLBCL
  • Identify DBLCL based on cell-of-origin classification